S. Bartel (Groningen, Netherlands), H. Heijink (Groningen, Netherlands)
This session is built from abstracts published on the ERS Congress platform from 23 August, in a PowerPoint format with a pre-recorded audio narration. The live session is scheduled from September 5-7 and each presenter will have a 5-minutes live, slide show presentation followed at the end of the session by 30-minutes general discussion.
Late Breaking Abstract - SARS-CoV-2 induces hyperinflammation in human macrophages via TLR4
S. Sahanic (Innsbruck, Austria), R. Hilbe (Innsbruck, Austria), J. Löffler-Ragg (Innsbruck, Austria), G. Weiss (Innsbruck, Austria), D. Wilflingseder (Innsbruck, Austria), W. Posch (Innsbruck, Austria), I. Tancevski (Innsbruck, Austria)
|    |
Late Breaking Abstract - ACE2 Overexpression Modulates Nicotine Receptors In Cell Type Specific Manner: Possible Relevance In Covid-19
T. Alves (Santos, Brazil), C. Bartholomeo (Santos, Brazil), T. Nicoliche (São Paulo, Brazil), R. Lemes (Diadema, Brazil), N. Pinheiro (Santos, Brazil), W. Tavares-De-Lima (São Paulo, Brazil), I. Tiberio (São Paulo, Brazil), A. Hamouda (Tyler, Brazil), K. Lee (Sao Paulo, Brazil), R. Ureshino (Diadema, Brazil), R. Stilhano (Sao Paulo, Brazil), C. Prado (Santos, Brazil)
| |
Late Breaking Abstract - Antagonizing COVID19-induced GPR4 alleviates lung and kidney injury
L. Kochbeck (Wuppertal, Germany), V. Duesterhus (Wuppertal, Germany), C. Ebert (Wuppertal, Germany), S. Horstmann (Wuppertal, Germany), K. Droebner (Wuppertal, Germany), M. Schmidt (Wuppertal, Germany), M. Lizé (Wuppertal, Germany)
| |
Late Breaking Abstract - MicroRNA signatures in critically ill COVID-19 patients: a bronchial aspirate study
M. Molinero García (Lleida, Spain), I. Benítez (Lleida, Spain), J. González (Lleida, Spain), C. Gort-Paniello (Lleida, Spain), A. Moncusí-Moix (Lleida, Spain), F. Rodríguez-Jara (Lleida, Spain), M. García-Hidalgo (Lleida, Spain), G. Torres (Lleida, Spain), J. Vengoechea (Lleida, Spain), S. Gómez (Lleida, Spain), R. Cabo (Lleida, Spain), J. Caballero (Lleida, Spain), J. Bermejo-Martin (Salamanca, Spain), A. Ceccato (Madrid, Spain), L. Fernández-Barat (Barcelona, Spain), R. Ferrer (Barcelona, Spain), D. Garcia-Gasulla (Barcelona, Spain), R. Menéndez (Valencia, Spain), A. Motos (Barcelona, Spain), O. Peñuelas (Madrid, Spain), J. Riera (Barcelona, Spain), A. Torres (Barcelona, Spain), F. Barbé (Lleida, Spain), D. De Gonzalo-Calvo (Lleida, Spain)
| |
Late Breaking Abstract - Increased Substance P levels in COVID-19 hospitalized patients
S. Smieszek (Washington, United States of America)
| |
Late Breaking Abstract - Effect of hydrogen therapy on the proteomic profile of exhaled breath condensate after recovery from COVID-19
A. Ryabokon (Moscow, Russian Federation), A. Kononikhin (Moscow, Russian Federation), A. Kozyr (Moscow, Russian Federation), N. Zakharova (Moscow, Russian Federation), M. Indeykina (Moscow, Russian Federation), A. Brzhozovskiy (Moscow, Russian Federation), L. Shogenova (Moscow, Russian Federation), E. Nikolaev (Moscow, Russian Federation), S. Varfolomeev (Moscow, Russian Federation), A. Chuchalin (Moscow, Russian Federation)
| |
Late Breaking Abstract - MicroRNA profiling informs on the pulmonary sequelae of COVID-19-induced ARDS
M. García Hidalgo (Lleida, Spain), I. Benítez (Lleida, Spain), M. Pérez-Pons (Lleida, Spain), J. González (Lleida, Spain), P. Carmona (Lleida, Spain), S. Santisteve (Lleida, Spain), C. Gort-Paniello (Lleida, Spain), A. Moncusí-Moix (Lleida, Spain), F. Rodríguez-Jara (Lleida, Spain), M. Molinero (Lleida, Spain), G. Torres (Lleida, Spain), J. Bermejo-Martín (Salamanca, Spain), A. Ceccato (Madrid, Spain), L. Fernández-Barat (Barcelona, Spain), R. Ferrer (Barcelona, Spain), D. García-Casulla (Barcelona, Spain), R. Menéndez (Valencia, Spain), A. Motos (Barcelona, Spain), Ó. Peñuelas (Getafe, Spain), J. Riera (Barcelona, Spain), A. Torres (Barcelona, Spain), F. Barbé (Lleida, Spain), D. De Gonzalo-Calvo (Lleida, Spain)
| |
Late Breaking Abstract - Monocyte-derived macrophages display an inflammatory memory several months post SARS-CoV-2 infection
S. Bohnacker (Munich, Germany), F. Hartung (Munich, Germany), F. Henkel (Munich, Germany), A. Quaranta (Stockholm, Sweden), J. Kolmert (Stockholm, Sweden), A. Priller (Munich, Germany), P. Lingor (Munich, Germany), A. Chaker (Munich, Germany), P. Knolle (Munich, Germany), C. Schmidt-Weber (Munich, Germany), C. Wheelock (Stockholm, Sweden), J. Esser-von Bieren (Munich, Germany)
| |
Late Breaking Abstract - Characterization of the immunological profile of COVID-19 patients and correlation of CD4+ and CD8+ T lymphocytes with disease severity during hospitalization.
K. Domvri (Thessaloniki, Greece), I. Tsiouprou (Thessaloniki, Greece), A. Apostolopoulos (Thessaloniki, Greece), M. Hadzimitrova (Thessaloniki, Greece), I. Fillipou (Thessaloniki, Greece), A. Pataka (Thessaloniki, Greece), S. Gougousis (Thessaloniki, Greece), T. Kontakiotis (Thessaloniki, Greece), D. Papakosta (Thessaloniki, Greece), E. Fouka (Thessaloniki, Greece), K. Porpodis (Thessaloniki, Greece)
| |
Late Breaking Abstract - A randomised, double-blind, placebo controlled, clinical trial evaluating imatinib in patients with severe COVID-19
J. Aman (Amsterdam, Netherlands), E. Duijvelaar (Amsterdam, Netherlands), L. Botros (Amsterdam, Netherlands), A. Kianzad (Amsterdam, Netherlands), J. Schippers (Amsterdam, Netherlands), P. Smeele (Amsterdam, Netherlands), S. Azhang (Den Haag, Netherlands), I. Bartelink (Amsterdam, Netherlands), P. Bet (Amsterdam, Netherlands), W. Boersma (Alkmaar, Netherlands), K. Boomars (Rotterdam, Netherlands), P. Bonta (Amsterdam, Netherlands), L. Bos (Amsterdam, Netherlands), J. Van Bragt (Amsterdam, Netherlands), G. Braunstahl (Rotterdam, Netherlands), L. Celant (Amsterdam, Netherlands), K. Eger (Amsterdam, Netherlands), M. Geelhoed (Leiden, Netherlands), Y. Van Glabbeek (Alkmaar, Netherlands), H. Grotjohan (Zwolle, Netherlands), L. Hagens (Amsterdam, Netherlands), C. Happe (Amsterdam, Netherlands), L. Heunks (Amsterdam, Netherlands), M. Van Den Heuvel (Nijmegen, Netherlands), W. Hoefsloot (Nijmegen, Netherlands), R. Hoek (Amsterdam, Netherlands), R. Hoekstra (Sneek, Netherlands), H. Hofstee (Den Haag, Netherlands), A. Vanhove (Amsterdam, Netherlands), N. Juffermans (Amsterdam, Netherlands), M. Lammers (Amsterdam, Netherlands), R. Kos (Amsterdam, Netherlands), M. Kemper (Amsterdam, Netherlands), P. Kunst (Amsterdam, Netherlands), I. Van Der Lee (Haarlem, Netherlands), L. Van Der Lee (Amsterdam, Netherlands), P. Mau-Asam (Amsterdam, Netherlands), A. Maitland-Van Der Zee (Amsterdam, Netherlands), A. Mieras (Amsterdam, Netherlands), E. Nossent (Amsterdam, Netherlands), M. Overbeek (Den Haag, Netherlands), L. Oswald (Rotterdam, Netherlands), N. Paternotte (Alkmaar, Netherlands), C. Pamplona (Amsterdam, Netherlands), N. Pronk (Apeldoorn, Netherlands), M. De Raaf (Amsterdam, Netherlands), E. Slob (Amsterdam, Netherlands), A. Serpa Neto (São Paulo, Brazil), M. Schultz (Amsterdam, Netherlands), M. Smit (Amsterdam, Netherlands), F. Smeenk (Eindhoven, Netherlands), J. Smits (Amsterdam, Netherlands), J. Stalenhoef (Amsterdam, Netherlands), P. Tuinman (Amsterdam, Netherlands), J. Wessels (Amsterdam, Netherlands), J. Van Wezenbeek (Amsterdam, Netherlands), A. Vonk Noordegraaf (Amsterdam, Netherlands), F. Handoko-De Man (Amsterdam, Netherlands), H. Bogaard (Amsterdam, Netherlands)
| |
Discussion
| |